Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection

European Journal of Immunology

Volumn 45, Issue 3, 2015, Pages 780-793

  Flórido, Manuela ^a   Pillay, Roman ^a   Gillis, Caitlin M ^a   Xia, Yingju ^b   Turner, Stephen J ^c   Triccas, James A ^d   Stambas, John ^b   Britton, Warwick J ^a,d  

^a CENTENARY INSTITUTE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CD4+ T cells; Interferon ; Lung; Recombinant influenza A virus; Tuberculosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; INFECTION PREVENTION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; GENETICS; IMMUNOLOGY; TUBERCULOSIS, PULMONARY;

BCG VACCINE; EPITOPE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; FEMALE; INFLUENZA A VIRUS; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 84924541430     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444954     Document Type: Article

References (55)

1. Pitt, J. M., Blankley, S., McShane, H. and O'Garra, A., Vaccination against tuberculosis: how can we better BCG? Microb. Pathog. 2013. 58: 2-16.
2. Tameris, M. D., Hatherill, M., Landry, B. S., Scriba, T. J., Snowden, M. A., Lockhart, S., Shea, J. E. et al., Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013. 381: 1021-1028.
3. Andersen, P., Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 1994. 62: 2536-2544.
4. Woodworth, J. S. and Behar, S. M., Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. Crit. Rev. Immunol. 2006. 26: 317-352.
5. Wang, J., Santosuosso, M., Ngai, P., Zganiacz, A. and Xing, Z., Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells. J. Immunol. 2004. 173: 4590-4597.
6. + T cells. Exp. Rev. Vacc. 2007. 6: 441-456.
7. + T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus. Immunol. Cell Biol. 2001. 79: 569-575.
8. Feng, C. G., Palendira, U., Demangel, C., Spratt, J. M., Malin, A. S. and Britton, W. J., Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect. Immun. 2001. 69: 4174-4176.
9. Chen, L., Wang, J., Zganiacz, A. and Xing, Z., Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect. Immun. 2004. 72: 238-246.
10. Wang, J., Thorson, L., Stokes, R. W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M. et al., Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 2004. 173: 6357-6365.
11. Goonetilleke, N. P., McShane, H., Hannan, C. M., Anderson, R. J., Brookes, R. H. and Hill, A. V., Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol. 2003. 171: 1602-1609.
12. Garcia-Contreras, L., Wong, Y. L., Muttil, P., Padilla, D., Sadoff, J., Derousse, J., Germishuizen, W. A. et al., Immunization by a bacterial aerosol. Proc. Natl. Acad. Sci. USA 2008. 105: 4656-4660.
13. Stylianou, E., Diogo, G. R., Pepponi, I., van Dolleweerd, C., Arias, M. A., Locht, C., Rider, C. C. et al., Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice. Eur. J. Immunol. 2014. 44: 440-449.
14. Ballester, M., Nembrini, C., Dhar, N., de Titta, A., de Piano, C., Pasquier, M., Simeoni, E. et al., Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine 2011. 29: 6959-6966.
15. Reljic, R., Sibley, L., Huang, J. M., Pepponi, I., Hoppe, A., Hong, H. A. and Cutting, S. M., Mucosal vaccination against tuberculosis using inert bioparticles. Infect. Immun. 2013. 81: 4071-4080.
16. Tyne, A. S., Chan, J. G., Shanahan, E. R., Atmosukarto, I., Chan, H. K., Britton, W. J. and West, N. P., TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines. Vaccine 2013. 31: 4322-4329.
17. White, A. D., Sibley, L., Dennis, M. J., Gooch, K., Betts, G., Edwards, N., Reyes-Sandoval, A. et al., Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques. Clin. Vaccine Immunol. 2013. 20: 663-672.
18. Florido, M., Grima, M. A., Gillis, C. M., Xia, Y., Turner, S. J., Triccas, J. A., Stambas, J. et al., Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection. J. Immunol. 2013. 191: 302-311.
19. Thakur, A., Pedersen, L. E. and Jungersen, G., Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 2012. 30: 4907-4920.
20. Lindenstrom, T., Agger, E. M., Korsholm, K. S., Darrah, P. A., Aagaard, C., Seder, R. A., Rosenkrands, I. et al., Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J. Immunol. 2009. 182: 8047-8055.
21. Lindenstrom, T., Knudsen, N. P., Agger, E. M. and Andersen, P., Control of chronic Mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells. J. Immunol. 2013. 190: 6311-6319.
22. Derrick, S. C., Yabe, I. M., Yang, A. and Morris, S. L., Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. Vaccine 2011. 29: 2902-2909.
23. Turner, D. L., Bickham, K. L., Thome, J. J., Kim, C. Y., D'Ovidio, F., Wherry, E. J. and Farber, D. L., Lung niches for the generation and maintenance of tissue-resident memory T cells. Mucosal Immunol. 2014. 7: 501-510.
24. Gallegos, A. M., Pamer, E. G. and Glickman, M. S., Delayed protection by ESAT-6-specific effector CD4 +T cells after airborne M. tuberculosis infection. J. Exp. Med. 2008. 205: 2359-2368.
25. Srivastava, S. and Ernst, J. D., Cutting edge: direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis in vivo. J. Immunol. 2013. 191: 1016-1020.
26. Lawn, S. D., Bekker, L. G., Middelkoop, K., Myer, L. and Wood, R., Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin. Inf. Dis. 2006. 42: 1040-1047.
27. Flory, C. M., Hubbard, R. D. and Collins, F. M., Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice. J. Leuk. Biol. 1992. 51: 225-229.
28. Scanga, C. A., Mohan, V. P., Yu, K., Joseph, H., Tanaka, K., Chan, J. and Flynn, J. L., Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J. Exp. Med. 2000. 192: 347-358.
29. Lin, P. L., Rutledge, T., Green, A. M., Bigbee, M., Fuhrman, C., Klein, E. and Flynn, J. L., CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques. AIDS Res. Hum. Retrovirus. 2012. 28: 1693-1702.
30. Teijaro, J. R., Turner, D., Pham, Q., Wherry, E. J., Lefrancois, L. and Farber, D. L., Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 2011. 187: 5510-5514.
31. Wu, T., Hu, Y., Lee, Y. T., Bouchard, K. R., Benechet, A., Khanna, K. and Cauley, L. S., Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J. Leuk. Biol. 2014. 95: 215-224.
32. Beverley, P. C., Sridhar, S., Lalvani, A. and Tchilian, E. Z., Harnessing local and systemic immunity for vaccines against tuberculosis. Mucosal Immunol. 2014. 7: 20-26.
33. Tchilian, E. Z., Ronan, E. O., de Lara, C., Lee, L. N., Franken, K. L., Vordermeier, M. H., Ottenhoff, T. H. et al., Simultaneous immunization against tuberculosis. PloS One 2011. 6: e27477.
34. Carter, N. J. and Curran, M. P., Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults. Drugs 2011. 71: 1591-1622.
35. Li, J., Arevalo, M. T. and Zeng, M., Engineering influenza viral vectors. Bioengineered 2013. 4: 9-14.
36. Sexton, A., De Rose, R., Reece, J. C., Alcantara, S., Loh, L., Moffat, J. M., Laurie, K. et al., Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques. J. Virol. 2009. 83: 7619-7628.
37. De Baets, S., Schepens, B., Sedeyn, K., Schotsaert, M., Roose, K., Bogaert, P., Fiers, W. et al., Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice. J. Virol. 2013. 87: 3314-3323.
38. Tan, A. C., Eriksson, E. M., Kedzierska, K., Deliyannis, G., Valkenburg, S. A., Zeng, W. and Jackson, D. C., Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope. Antiviral Res. 2012. 94: 168-178.
39. Martina, B. E., van den Doel, P., Koraka, P., van Amerongen, G., Spohn, G., Haagmans, B. L., Provacia, L. B. et al., A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus. PloS One 2011. 6: e18995.
40. Kedzierska, K., Curtis, J. M., Valkenburg, S. A., Hatton, L. A., Kiu, H., Doherty, P. C. and Kedzierski, L., Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses. PloS One 2012. 7: e33161.
41. Miyahira, Y., Garcia-Sastre, A., Rodriguez, D., Rodriguez, J. R., Murata, K., Tsuji, M., Palese, P. et al., Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Proc. Natl. Acad. Sci. USA 1998. 95: 3954-3959.
42. Sereinig, S., Stukova, M., Zabolotnyh, N., Ferko, B., Kittel, C., Romanova, J., Vinogradova, T. et al., Influenza virus NS vectors expressing the Mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge. Clin. Vaccine Immunol. 2006. 13: 898-904.
43. Kamath, A., Woodworth, J. S. and Behar, S. M., Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection. J. Immunol. 2006. 177: 6361-6369.
44. Billeskov, R., Elvang, T. T., Andersen, P. L. and Dietrich, J., The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity. PloS One 2012. 7: e39909.
45. Billeskov, R., Christensen, J. P., Aagaard, C., Andersen, P. and Dietrich, J., Comparing adjuvanted h28 and modified vaccinia virus ankara expressing h28 in a mouse and a non-human primate tuberculosis model. PloS One 2013. 8: e72185.
46. Baldwin, S. L., Ching, L. K., Pine, S. O., Moutaftsi, M., Lucas, E., Vallur, A., Orr, M. T. et al., Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells. J. Immunol. 2013. 191: 2514-2525.
47. Lindenstrom, T., Aagaard, C., Christensen, D., Agger, E. M. and Andersen, P., High-frequency vaccine-induced CD8(+) T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection. Eur. J. Immunol. 2014. 44: 1699-1709.
48. Wu, Y., Woodworth, J. S., Shin, D. S., Morris, S. and Behar, S. M., Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection. Infect. Immun. 2008. 76: 2249-2255.
49. Chen, C. Y., Huang, D., Wang, R. C., Shen, L., Zeng, G., Yao, S., Shen, Y. et al., A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog. 2009. 5: e1000392.
50. Rahman, S., Magalhaes, I., Rahman, J., Ahmed, R. K., Sizemore, D. R., Scanga, C. A., Weichold, F. et al., Prime-boost vaccination with rBCG/rAd35 enhances CD8(+) cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates. Mol. Med. 2012. 18: 647-658.
51. Ryan, A. A., Nambiar, J. K., Wozniak, T. M., Roediger, B., Shklovskaya, E., Britton, W. J., Fazekas de St Groth, B. et al., Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection. J. Immunol. 2009. 182: 7172-7177.
52. van Pinxteren, L. A., Cassidy, J. P., Smedegaard, B. H., Agger, E. M. and Andersen, P., Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 2000. 30: 3689-3698.
53. Sousa, A. O., Mazzaccaro, R. J., Russell, R. G., Lee, F. K., Turner, O. C., Hong, S., Van Kaer, L. et al., Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 2000. 97: 4204-4208.
54. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. and Webster, R. G., A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 2000. 97: 6108-6113.
55. Cukalac, T., Moffat, J. M., Venturi, V., Davenport, M. P., Doherty, P. C., Turner, S. J. and Stambas, J., Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus. Vaccine 2009. 27: 6755-6761.